Skip to main navigation Skip to search Skip to main content

Biodistribution and respiratory toxicity of chloromethylisothiazolinone/methylisothiazolinone following intranasal and intratracheal administration

  • Mi Kyung Song
  • , Jung Eun Park
  • , Seung Hun Ryu
  • , Yong Wook Baek
  • , Young Hee Kim
  • , Dong Im Kim
  • , Sung Hoon Yoon
  • , Hyunil Shin
  • , Jongho Jeon
  • , Kyuhong Lee
  • Korea Institute of Toxicology
  • University of Science and Technology UST
  • Kyungpook National University
  • National Institute of Environmental Research
  • Ltd.

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

A variety of isothiazolinone-containing small molecules have been registered and used as chemical additives in many household products. However, their biodistribution and potential harmful effects on human health, especially respiratory effects, were not yet identified in sufficient detail. The purpose of this study was to investigate whether a biocide comprising a mixture of chloromethylisothiazolinone (CMIT) and methylisothiazolinone (MIT) could reach the lungs and induce lung injury when exposure occurs by two administration routes involving the respiratory tract: intratracheal and intranasal instillation. To investigate the biodistribution of CMIT/MIT, we quantified the uptake of 14C-labeled CMIT/MIT in experimental animals for up to seven days after intratracheal and intranasal instillation. In the toxicity study, lung injury was assessed in mice using total inflammatory cell count in bronchoalveolar lavage fluid (BALF) and lung histopathology. The results of the biodistribution study indicated that CMIT/MIT were rapidly distributed throughout the respiratory tract. Using quantitative whole-body autoradiogram analysis, we confirmed that following intranasal exposure, CMIT/MIT reached the lungs via the respiratory tract (nose–trachea–lung). After 5 min post intratracheal and intranasal instillation, the amount of radiotracer ([14C]CMIT/MIT) in the lungs was 2720 ng g−1 and 752 ng g−1 tissue, respectively, and lung damage was observed. A higher amount of the radiotracer resulted in higher toxicity. Both intratracheal and intranasal instillation of CMIT/MIT increased inflammatory cell counts in the BALF and induced injuries in the alveoli. The frequency and the severity scores of injuries caused by intratracheal instillation were approximately-four to five times higher than those induced by intranasal instillation. Therefore, we concluded that CMIT/MIT could reach the lungs following nasal and intratracheal exposure and cause lung injuries, and the extent of injury was dependent on the exposure dose.

Original languageEnglish
Article number107643
JournalEnvironment International
Volume170
DOIs
StatePublished - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biodistribution
  • Chloromethylisothiazolinone
  • Lung injury
  • Methylisothiazolinone
  • Quantitative whole-body autoradiography
  • Radiolabeling

Fingerprint

Dive into the research topics of 'Biodistribution and respiratory toxicity of chloromethylisothiazolinone/methylisothiazolinone following intranasal and intratracheal administration'. Together they form a unique fingerprint.

Cite this